Treatment
Most recent articles
Can Antidepressants Influence the Course of Inflammatory Bowel Disease? The Current State of Research
Inflammatory bowel disease (IBD) is a generic term used to describe a group of chronic and relapsing inflammatory disorders of the gastrointestinal...
The Most Significant Advances in the Management of Crohn’s Disease
Biological Agents Infliximab (a chimaeric humanised anti-tumour necrosis factor [TNF]-α antibody) was the first TNF-α inhibitor approved for the...
Endoscopic Healing as a Therapeutic Target in Crohn’s Disease
Historically, the treatment goals for Crohn’s disease were mainly palliative: to improve symptoms and induce and maintain clinical response and...
Certolizumab Pegol in Crohn’s Disease
Traditional Therapies in Crohn’s Disease Anti-inflammatory drugs and oral immunosuppressants have traditionally been the mainstay for treating...
Update in Medical Therapy of Ulcerative Colitis
Mild to Moderate Ulcerative Colitis 5-aminosalicylic acid (5-ASA) has been extensively evaluated and is considered the first-line therapy for mild to...
